MENU
ALKS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Alkermes (ALKS) Earnings Date & Reports

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

ALKS is expected to report earnings to fall 14.39% to 41 cents per share on February 12

Alkermes ALKS Stock Earnings Reports
Q4'25
Est.
$0.42
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.16
Q1'25
Missed
by $0.18
Q4'24
Beat
by $0.30
The last earnings report on October 28 showed earnings per share of 49 cents, beating the estimate of 37 cents. With 3.35M shares outstanding, the current market capitalization sits at 5.12B.
View a ticker or compare two or three
ALKS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALKS showed earnings on October 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Burlington Road
Phone
+353 17728000
Employees
2100
Web
https://www.alkermes.com